Emerging BioTalk
  • Home
  • About Us
  • Contact
  • Search
  • Menu

Another Successful Biotech Start-Up Symposium Is In The Books

January 7, 2022/in Bioprocessing, Frontpage Article, News /by Jessica Hogan

Register to our next Advance Biotech Grant Program.

On November 17th and 18th, over 200 start-up pioneers gathered virtually for the Biotech Start-Up Symposium. The event included over a dozen speakers from industry-leading biotech companies and venture capital firms. The program was hosted by Susan Moore and Jessica Hogan and featured presentations by industry experts, unique networking opportunities, a virtual tour of the M LabTM Collaboration Center and one-on-one discussions with local start-up consultants. During the two-day event, the speakers provided insights into how to successfully navigate today’s emerging biotech landscape and how biotech startups can raise venture capital to take their ideas from the lab to the clinical phase.

Among the day one highlights were presentations on successfully raising venture capital and what start-ups need to know before pitching their idea. Attendees also gleaned valuable insights into biomanufacturing and selecting the right Contract Development and Manufacturing Organization (CDMO).

Day two featured presentations by the finalists for the Advance Biotech Grant Award, which will include products, services, and consultation to help accelerate development. The finalists included the privately-held preclinical stage company Mucommune, emerging mRNA therapeutics company Strand Therapeutics and eventual winner, Elevian. The winner was awarded $255K in products and services and the other finalists were awarded $10K in products and services. The Advance Biotech Grant Program is a global program that helps biotech startups understand the challenges in the quest to push the next generation of drugs to market.

Per the company’s website, Elevian is an emerging biotech company developing medicines that promote recovery and regeneration.  Elevian’s lead program is a recombinant protein (rGDF11) for the treatment of stroke in the days following the event, for which there are currently no viable treatments. The beneficial effects of rGDF11 are not limited to stroke. rGDF11 has been demonstrated to promote recovery and regeneration in several preclinical models of aging-related diseases, including cardiovascular, neurological, metabolic, pulmonary, renal, inflammatory, and skeletal muscle dysfunction.

Learn more about our Advance Biotech Grant Program.

 

  • Author
  • Recent Posts
Jessica Hogan
Latest posts by Jessica Hogan (see all)
  • 5 Minutes could win you $275,000 in products and services! - January 30, 2023
  • Enter for a chance to win $275,000 in products and services! - January 9, 2023
  • Navigating The Regulatory Maze: Fundamentals for Drug Development - May 25, 2022
+1
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on LinkedIn
  • Share by Mail
http://emergingbiotalk.com/wp-content/uploads/2020/06/Merck_Lab_mercrobe_woman_v1-generic.jpg 630 1500 Jessica Hogan http://emergingbiotalk.com/wp-content/uploads/2020/05/emergingbiotalk-header.png Jessica Hogan2022-01-07 13:14:272022-02-08 18:39:11Another Successful Biotech Start-Up Symposium Is In The Books

Biotech Resource Hub >>

  • SUBSCRIBE TO OUR BLOG
  • SUBMIT YOUR BLOG POST

Latest News

  • 5 Minutes could win you $275,000 in products and services!January 30, 2023 - 8:50 am
  • Upcoming Seminar in India: Fast track through regulatory challengesFebruary 6, 2023 - 1:10 pm
  • Enter for a chance to win $275,000 in products and services!January 9, 2023 - 11:14 am

Categories

  • Bioprocessing
  • Biosafety Testing
  • End-to-End Solutions
  • Frontpage Article
  • Gene Therapy
  • Investigator's Brochure
  • News
  • Uncategorized
  • Vaccines
  • Viral Vectors
  • Webinar

Archives

  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • May 2020
  • April 2020
  • SUBSCRIBE TO OUR BLOG
  • SUBMIT YOUR BLOG POST

Latest News

  • 5 Minutes could win you $275,000 in products and services!January 30, 2023 - 8:50 am
  • Upcoming Seminar in India: Fast track through regulatory challengesFebruary 6, 2023 - 1:10 pm
  • Enter for a chance to win $275,000 in products and services!January 9, 2023 - 11:14 am

Categories

  • Bioprocessing
  • Biosafety Testing
  • End-to-End Solutions
  • Frontpage Article
  • Gene Therapy
  • Investigator's Brochure
  • News
  • Uncategorized
  • Vaccines
  • Viral Vectors
  • Webinar

Archives

  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • May 2020
  • April 2020

Tags

applications bioprocessing biotech blazar Congratulations Content education Europe FDA Format gene therapy grant grants Investigator's Brochure molecule new NGS Pharmaceuticals program services symposia tags things Tone VAR2 viral assurance viral clearance virus virus detection winner

Business Hours

Our support Hotline is available 24 Hours a day: (555) 343 456 7891

  • Monday-Friday: 9am to 5pm
  • Saturday: 10am to 2pm
  • Sunday: Closed

Latest News

  • 5 Minutes could win you $275,000 in products and services!January 30, 2023 - 8:50 am
  • Upcoming Seminar in India: Fast track through regulatory challengesFebruary 6, 2023 - 1:10 pm
  • Enter for a chance to win $275,000 in products and services!January 9, 2023 - 11:14 am
  • The Future of BiopharmaDecember 6, 2022 - 4:39 am
  • Last chance: 3rd Annual Startup Symposium – Day 3November 10, 2022 - 5:39 am
  • The Lack of Funding for Women Entrepreneurs Doesn’t Stop Them from Launching – But We Still Have a Long Way to Go – And We Can Help Each Other. Assurea is ROOTING FOR YOU!October 21, 2022 - 8:27 am

Categories

  • Bioprocessing
  • Biosafety Testing
  • End-to-End Solutions
  • Frontpage Article
  • Gene Therapy
  • Investigator's Brochure
  • News
  • Uncategorized
  • Vaccines
  • Viral Vectors
  • Webinar
  • Author
  • Recent Posts
Jessica Hogan
Latest posts by Jessica Hogan (see all)
  • 5 Minutes could win you $275,000 in products and services! - January 30, 2023
  • Enter for a chance to win $275,000 in products and services! - January 9, 2023
  • Navigating The Regulatory Maze: Fundamentals for Drug Development - May 25, 2022
+1
© 2020 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved. | Privacy Policy | Cookie Settings
Congratulations Elevian! business meeting The Post-COVID-19 State of Biomanufacturing News from the Biotech Start-up ...
Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. We use cookies in our website to give you the most relevant experience. By clicking or navigating the site, you are accepting the use of all our cookies according to our Cookie Policy / Privacy Statement. You are free to decide in the Cookie Settings which categories you would like to allow. Please note that depending on what you select, the full functionality of the website may no longer be available. You may review and change your choices at any time. Further information can be found in our Privacy Policy

Accept All CookiesCookie Settings

Cookie and Privacy Settings



Cookie Preferences

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about how we use and share your data, please follow this link.
Privacy Statement

Necessary

Always Active
These cookies are necessary for the website to operate. Our website cannot function without these cookies and they can only be disabled by changing your browser preferences.

Functional

These cookies enable the provision of advanced functionalities and are used for personalization. The cookies are set in particular in response to your actions and depend on your specific service requests (e.g., pop-up notification choices).Changes will take effect once you reload the page.

Targeting

These cookies may be set to learn more about your interests and show you relevant ads on other websites. These cookies work by uniquely identifying your browser and device. By integrating these cookies, we aim to learn more about your interests and your surfing behavior and to be able to place our advertising in a targeted manner.

Confirm My ChoicesAllow AllDisable All

loading

Please wait while you are redirected to the right page...

Please share your location to continue.

Check our help guide for more info.

share your location